These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16116318)

  • 41. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
    Bruzzese E; Raia V; Spagnuolo MI; Volpicelli M; De Marco G; Maiuri L; Guarino A
    Clin Nutr; 2007 Jun; 26(3):322-8. PubMed ID: 17360077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
    Wenzl HH; Primas C; Novacek G; Teml A; Öfferlbauer-Ernst A; Högenauer C; Vogelsang H; Petritsch W; Reinisch W
    Dig Dis Sci; 2015 May; 60(5):1414-23. PubMed ID: 25381202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants.
    Viljanen M; Kuitunen M; Haahtela T; Juntunen-Backman K; Korpela R; Savilahti E
    Pediatr Allergy Immunol; 2005 Feb; 16(1):65-71. PubMed ID: 15693914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lactobacillus GG for treatment of acute childhood diarrhoea: an open labelled, randomized controlled trial.
    Aggarwal S; Upadhyay A; Shah D; Teotia N; Agarwal A; Jaiswal V
    Indian J Med Res; 2014 Mar; 139(3):379-85. PubMed ID: 24820831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome.
    Viljanen M; Pohjavuori E; Haahtela T; Korpela R; Kuitunen M; Sarnesto A; Vaarala O; Savilahti E
    J Allergy Clin Immunol; 2005 Jun; 115(6):1254-9. PubMed ID: 15940143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.
    Fölster-Holst R; Müller F; Schnopp N; Abeck D; Kreiselmaier I; Lenz T; von Rüden U; Schrezenmeir J; Christophers E; Weichenthal M
    Br J Dermatol; 2006 Dec; 155(6):1256-61. PubMed ID: 17107398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probiotics for prevention and treatment of diarrhea.
    Guandalini S
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
    Sandborn WJ; Löfberg R; Feagan BG; Hanauer SB; Campieri M; Greenberg GR
    Am J Gastroenterol; 2005 Aug; 100(8):1780-7. PubMed ID: 16086715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Double-blind, Randomized, Placebo-controlled Trial of Lactobacillus acidophilus for the Treatment of Acute Watery Diarrhea in Vietnamese Children.
    Hong Chau TT; Minh Chau NN; Hoang Le NT; Chung The H; Voong Vinh P; Nguyen To NT; Ngoc NM; Tuan HM; Chau Ngoc TL; Kolader ME; Farrar JJ; Wolbers M; Thwaites GE; Baker S;
    Pediatr Infect Dis J; 2018 Jan; 37(1):35-42. PubMed ID: 28787388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
    Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
    J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease.
    Fujimori S; Tatsuguchi A; Gudis K; Kishida T; Mitsui K; Ehara A; Kobayashi T; Sekita Y; Seo T; Sakamoto C
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1199-204. PubMed ID: 17688660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.
    Bruzzese E; Raia V; Ruberto E; Scotto R; Giannattasio A; Bruzzese D; Cavicchi MC; Francalanci M; Colombo C; Faelli N; Daccò V; Magazzù G; Costa S; Lucidi V; Majo F; Guarino A
    J Cyst Fibros; 2018 May; 17(3):375-382. PubMed ID: 29128317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
    Hanauer S; Sandborn WJ; Persson A; Persson T
    Aliment Pharmacol Ther; 2005 Feb; 21(4):363-71. PubMed ID: 15709986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial.
    Wischmeyer PE; Tang H; Ren Y; Bohannon L; Jiang D; Bergens M; Ramirez ZE; Andermann TM; Messina JA; Sung JA; Jensen D; Jung SH; Artica A; Britt A; Bush A; Johnson E; Lew MV; Winthrop H; Pamanes C; Racioppi A; Zhao AT; Wan Z; Surana NK; Sung AD
    Clin Nutr; 2024 Jan; 43(1):259-267. PubMed ID: 38103462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora.
    Kuisma J; Mentula S; Jarvinen H; Kahri A; Saxelin M; Farkkila M
    Aliment Pharmacol Ther; 2003 Feb; 17(4):509-15. PubMed ID: 12622759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised clinical trial: a Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo.
    Bruzzese E; Fedele MC; Bruzzese D; Viscovo S; Giannattasio A; Mandato C; Siani P; Guarino A
    Aliment Pharmacol Ther; 2016 Sep; 44(6):568-75. PubMed ID: 27464469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.
    O'Donoghue DP; Dawson AM; Powell-Tuck J; Bown RL; Lennard-Jones JE
    Lancet; 1978 Nov; 2(8097):955-7. PubMed ID: 81986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.